Ocean Bio Chem Inc OBCI
We take great care to ensure that the data presented and summarized in this overview for OCEAN BIO CHEM INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in OBCI
Top Purchases
Top Sells
About OBCI
Insider Transactions at OBCI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Aug 09
2022
|
John B Turner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
80,272
-100.0%
|
$1,043,536
$13.08 P/Share
|
|
Aug 09
2022
|
Kim Krause Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-100.0%
|
$65,000
$13.08 P/Share
|
|
Aug 09
2022
|
James M Kolisch Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
72,266
-100.0%
|
$939,458
$13.08 P/Share
|
|
Aug 09
2022
|
Gregor M Dornau EVP Sales & Marketing |
SELL
Sale (or disposition) back to the issuer
|
Direct |
456,878
-100.0%
|
$5,939,414
$13.08 P/Share
|
|
Aug 09
2022
|
William Dudman Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
256,910
-100.0%
|
$3,339,830
$13.08 P/Share
|
|
Aug 09
2022
|
Peter G Dornau Chairman, President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,537,628
-100.0%
|
$58,989,164
$13.08 P/Share
|
|
Aug 09
2022
|
Peter G Dornau Chairman, President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
265,342
-100.0%
|
$3,449,446
$13.08 P/Share
|
|
Aug 09
2022
|
Diana Conard Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,973
-100.0%
|
$77,649
$13.08 P/Share
|
|
Aug 09
2022
|
Jeffrey Barocas Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
179,331
-100.0%
|
$2,331,303
$13.08 P/Share
|
|
Jan 03
2022
|
Peter Dornau Family, LLC > 10% Shareholder |
BUY
Bona fide gift
|
Direct |
6,400
+0.14%
|
-
|
|
Jan 03
2022
|
Peter G Dornau Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
6,400
+0.14%
|
-
|
|
Jan 03
2022
|
Peter G Dornau Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
6,400
-2.36%
|
-
|
|
Jan 03
2022
|
Peter G Dornau Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+2.3%
|
-
|
|
Nov 11
2021
|
Gregor M Dornau EVP Sales & Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+0.74%
|
-
|
|
Nov 11
2021
|
Jeffrey Barocas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+1.86%
|
-
|
|
Nov 11
2021
|
William Dudman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+1.31%
|
-
|
|
Jun 07
2021
|
Diana Conard Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+14.34%
|
-
|
|
Jun 07
2021
|
James M Kolisch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.36%
|
-
|
|
Jun 07
2021
|
John B Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.23%
|
-
|
|
Jun 07
2021
|
Kim Krause Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+16.67%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders